CTN :35985103
05 Jun, 2024
NA
Tender For bid to ras supply of bimatoprost 0.01 percent w oblique v with bak 0.02 percent 3ml , cap of tocotrienols 12.5 mg plus resveratrol 5 mg percent lutein5 mg plus astaxanthin 4 mg plus zeaxanthin1 mg plus zinc 12 mg plus copper 2 mg , bromfenac 0.09 percwnt eye drops bottle of 5 ml , brinzolamide micronized suspension 1 percent with bak 0.02percent , eye drop atropine 0.1percent , brimonidine tartrate 0.1 percent with cmc eye drops 5 ml bottle , brimonidine tartrate 0.15percent plus stabilized oxychloro complex purite plus carboxymethyl cellulose , brimonidine tartrate 0.2percent plus timolol 0.5percent plus benzalkonium chloride 0.005percent bak , atropine sulphate 1percent w oblique v bott of 3 ml , cyclopentolate hcl 1 percent opth soln bottle of 5 ml , eye drops latanoprost 0.005 percent 2.5 ml , moxifloxacin eye ointment 0.5 percent w oblique w coma 5g , tropicamide with phenylephrine with lidocaine for intracameral use 1 ml , eye drop nepafenac 1 mg with wet milling technology micronized particle coma zero bkc coma polyhexamethylene biguanide hydrochloride 0.01 percent , tafluprost 0.0015 percent w oblique v preservative free single use vials coma pack of 30 unims , nepafenac 0.3 percent w oblique v eye drops coma bottle of 5 ml , tacrolimus eye ointment 0.03 percent 5g , mineral oil coma propylene glycol 0.6 percent hydroxypropyl guar 8a sorbitol and polyquad polyquaternium-1 0.001 percent technology coma 10ml , loteprednol etabonate 0.5 percent plus gatifloxacin0.3percent with bak 0.005 percent , lutein 10 mg zeaxanthin 2 mg class="text-red-selected">vitamin c 40 mg zin
c 13.2 mg selenium 40 m
cg
class="text-red-sele
cted">vitamin b6 2.4 mg
class="text-red-sele
cted">vitamin b12 2.2m
cg foli
c a
cid 110m
cg
coma no beta
carotene
capsules , gan
ci
clovir ophthalmi
c gel 0.15 per
cent w oblique v , eye gel hydroxypropyl methyl
cellulose bre
cket hypromellose bre
cket 0.3per
cent
coma
carbomer 980 10 gm tube , eye drop dorzolamide 2per
cent w oblique v and timolol 0.5 per
cent w oblique v
composition dorzolamide hydro
chloride ip 20 mg and timolol maleate ip 5 mg, benzalkonium
chloride 5ml bottle , eye drop gatifloxa
cin 0.3per
cent with bak 0.005per
cent 5 ml , eye drop besifloxa
cin with durasite te
chnology , difluprednate eye drop 5 ml , sodium
chloride 6per
cent w oblique w ointment tube of 3 gm , sodium
chloride eye drops 5per
cent
coma 5 ml bott , tropi
camide 1per
cent with 5per
cent phenylephrine eye drop bott of 5 ml , atropine sulphate oint 1per
cent tube of 3 gm , dorzolamide 2per
cent plus timolol 0.5 per
cent
coma bott of 5 ml , olopatadine huydro
chloride 0.1per
cent ophthalmi
c soln bottt of 5 ml , propara
caine eye drops 0.5per
cent bott of 15 ml , moxifloxa
cin h
cl 0.5 per
cent plus dexamethasone 0.1 per
cent ophthalmi
c soln bott of 5 ml , eye drop brimonidine 0.2per
cent plus brinzolamide 1per
cent
coma bott of 5 ml , travoprost 0.004per
cent and timolol 0.5per
cent polyquad 0.001per
cent
coma 2.5 ml bott ,
cy
closporine emulsion 0.05per
cent with gly
cerine
coma
castor oil polysorbate 80
carbomer 1342 preservative free aa pa
ck of 30 vial of 0.4 ml ea
ch , nepafena
c mi
cronised suspension 0.1per
cent with bak free
coma iit te
chnology in pa
cking of 5ml , eye drop azelastine , sodium hyaluronate 0.1per
cent w oblique v sodium
chloride benzalkonium
chloride
c12 0.0015per
cent in dimple bottle te
chnology 5 ml , lotepredenol etabonate 0.5per
cent bott of 5 ml bid details/ 2 / 35